跳至主要内容
临床试验/JPRN-UMIN000013271
JPRN-UMIN000013271进行中(未招募)未知

An exploratory observational study to investigate patient background factors of Ramelteon responders

Takeda Pharmaceutical Company Limited0 个研究点目标入组 2,200 人开始时间: 2014年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
入组人数
2,200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 1.A patient with a diagnosis of insomnia with difficulty falling asleep who has been started on treatment with oral Ramelteon 8 mg/day
  • 2.A patient who has answered the Insomnia Severity Index (ISI) questionnaire and the health-related QOL scale Short Form-8 (SF-8) in routine clinical settings before the start of Ramelteon therapy
  • 3.A patient who has given consent to the use of clinical information for the study at 20 years of age or older

排除标准

  • 1.A patient who has received Ramelteon within 4 weeks before the start of oral ramelteon therapy
  • 2.A patient with dementia
  • 3.A patient with a history of hypersensitivity to Ramelteon
  • 4.A patient with severe hepatic impairment
  • 5.A patient with a history of drug abuse
  • 6.A patient with psychiatric disease in an unstable condition
  • 7.A patient who, in the opinion of the principal investigator or co-investigator, is not appropriate for the study

研究者

相似试验